Fielder Capital Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$403K Buy
646
+11
+2% +$6.44K 0.08% 165
2026
Q2
$336K Sell
635
-57
-8% -$26.3K 0.07% 186
2026
Q1
$332K Sell
692
-126
-15% -$64.5K 0.07% 174
2025
Q4
$459K Buy
818
+87
+12% +$49.4K 0.1% 125
2025
Q3
$376K Buy
731
+90
+14% +$39.3K 0.09% 141
2025
Q2
$201K Sell
641
-56
-8% -$16.8K 0.05% 230
2025
Q1
$212K Buy
+697
New +$234K 0.06% 201
2024
Q3
– Sell
-557
Closed -$229K – 219
2024
Q2
$229K Sell
557
-61
-10% -$24.2K 0.09% 153
2024
Q1
$250K Buy
+618
New +$217K 0.11% 129

Other funds holding MEDP

Fielder Capital Group's MEDP Position: Q3 2026 in Review

Fielder Capital Group increased its Medpace (MEDP) stake by 1.7% in Q3 2026, buying an estimated $6.44K and bringing the position to 646 shares worth $403K. The position accounts for 0.08% of the portfolio, ranked #165.

Fielder Capital Group first reported a position in MEDP in Q1 2024 and has held it in 9 quarters since. The position peaked at $459K in Q4 2025. 762 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Fielder Capital Group held 646 shares of Medpace worth $403K as of Q3 2026.
  • Fielder Capital Group bought 11 Medpace shares in Q3 2026, an estimated $6.44K.
  • Medpace made up 0.08% of Fielder Capital Group's portfolio in Q3 2026, its #165 holding.
  • Fielder Capital Group first reported a position in Medpace in Q1 2024 and has held it in 9 quarters since.
  • Fielder Capital Group's Medpace position peaked at $459K in Q4 2025.
  • 762 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Fielder Capital Group's 13F filing for Q3 2026, filed 12 Nov 2026.